Association between genetic variants in glutathione peroxidase 1 (GPx1) gene, GPx activity and the risk of prostate cancer

Minerva Urologica e Nefrologica

Volumn 63, Issue 3, 2011, Pages 183-190

  Kucukgergin, C ^a   Gokpinar, M ^a   Sanli, O ^a   Tefik, T ^a   Oktar, T ^a   Seckin, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Genetic diseases, inborn; Glutathione peroxidase GPX1; Prostate cancer

Indexed keywords

GLUTATHIONE PEROXIDASE 1; LEUCINE; PROLINE; PROSTATE SPECIFIC ANTIGEN;

AGE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

CASE-CONTROL STUDIES; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84055212284     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ambrosone CB. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2000;2:903-17. (Pubitemid 32062336)
2. Beckett GJ, Arthur JR. Selenium and endocrine systems. J Endocrinol 2005;184:455-65. (Pubitemid 40426009)
3. Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S et al. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 2000;59:163-70. (Pubitemid 30216139)
4. Brigelius-Flohé R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 1999;27:951-65. (Pubitemid 29507469)
5. Ishida K, Morino T, Takagi K, Sukenaga Y. Nucleotide sequence of a human gene for glutathione peroxidase. Nucleic Acids Res 1987;15:10051.
6. Moscow JA, Schmidt L, Ingram DT, Gnarra J, Johnson B, Cowan KH. Loss of heterozygosity of the human cytosolic glutathione peroxidase 1 gene in lung cancer. Carcinogenesis 1994;15:2769-73.
7. Ratnasinghe D, Tangrea JA, Andersen MR, Barrett MJ, Virtamo J, Taylor PR et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 2000;60:6381-3.
8. Kote-Jarai Z, Durocher F, Edwards SM, Hamoudi R, Jackson RA, Ardern-Jones A et al. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Dis 2002;5:189-92.
9. Ichimura Y, Habuchi T, Tsuchiya N, Wang L, Oyama C, Sato K et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol 2004;172:728-32. (Pubitemid 38900250)
10. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003;63:3347-51. (Pubitemid 36735893)
11. Ravn-Haren G, Olsen A, Tjønneland A, Dragsted LO, Nexø BA, Wallin H et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006;27:820-5.
12. Cox DG, Hankinson SE, Kraft P, Hunter DJ. No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:1821-2. (Pubitemid 39482964)
13. Knight JA, Onay UV, Wells S, Li H, Shi EJ, Andrulis IL et al. Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2004;13:146-9. (Pubitemid 38116633)
14. Hansen R, Saebo M, Skjelbred CF, Nexo BA, Hagen PC, Bock G et al. GPX 1 Pro198Leu and OGG1 Ser-326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett 2005;229:85-91. (Pubitemid 41262543)
15. Yang P, Bamlet WR, Ebbert JO, Taylor WR, de Andrade M.Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 2000;25:1935-44.
16. Raaschou-Nielsen O, Sørensen M, Hansen RD, Frederiksen K, Tjønneland A, Overvad K et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett 2007;247:293-300. (Pubitemid 46240616)
17. Forsberg L, De Faire U, Marklund SL, Andersson PM, Stegmayr B, Morgenstern R. Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis 2000;26:423-6. (Pubitemid 32037410)
18. Jablonska E, Gromadzinska J, Reszka E, Wasowicz W, Sobala W, Szeszenia-Dabrowska N et al. Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nutr 2009;48:383-6.
19. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin 1997;47:273-87. (Pubitemid 27405933)
20. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001;389:84-93. (Pubitemid 32911546)
21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
22. Srivastava DSL, Mittal RD. Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer. Ind J Clin Bichem 2005;20:162-5. (Pubitemid 41215721)
23. Choi JY, Neuhouser ML, Barnett M, Hudson M, Kristal AR, Thornquist M et al. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007;16:1115-20. (Pubitemid 46984946)
24. Arsova-Sarafinovska Z, Matevska N, Eken A, Petrovski D, Banev S, Dzikova S et al. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int Urol Nephrol 2009;41:63-70.
25. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-312. (Pubitemid 33145299)
26. Jung K, Seidel B, Rudolph B, Lein M, Cronauer MV, Henke W et al. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic Biol Med 1997;23:127-33. (Pubitemid 27217016)
27. Yeh CC, Hou MF, Tsai SM, Lin SK, Hsiao JK, Huang JC et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta 2005;361:104-11.
28. Rajneesh CP, Manimaran A, Sasikala KR, Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J 2008;49:640-3.
29. Guo M, Hay BA. Cell proliferation and apoptosis. Curr Opin Cell Biol 1999;11:745-52.
30. Gouaze V, Mirault ME, Carpentier S, Salvayre R, Levade T, Andrieu-Abadie N. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol 2001;60:488-96. (Pubitemid 32781555)
31. Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, Inouye M, Huang MT. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res 1997;57:1468-74. (Pubitemid 27175562)